ArticleBiomedicines2024

Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab.

Diego Bagnasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.